Journal article
SARS-CoV-2 challenge studies: ethics and risk minimisation
Abstract
COVID-19 poses an exceptional threat to global public health and well-being. Recognition of the need to develop effective vaccines at unprecedented speed has led to calls to accelerate research pathways ethically, including by conducting challenge studies (also known as controlled human infection studies (CHIs)) with SARS-CoV-2 (the virus which causes COVID-19). Such research is controversial, with concerns being raised about the social, legal, …
Authors
Bull S; Jamrozik E; Binik A; Parker MJ
Journal
Journal of Medical Ethics, Vol. 47, No. 12, pp. e79–e79
Publisher
BMJ
Publication Date
December 2021
DOI
10.1136/medethics-2020-106504
ISSN
0306-6800